SCHEMBL14557948

SCHEMBL14557948

CCCOc1ccc(-c2ccc(C(=O)N(CC)CC)cc2)cc1C(=O)NC(CO)Cc1c[nH]c2ccc(F)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 2/20 0.40
TRPV1 Q8NER1 2/20 0.39
PPARG P37231 2/20 0.38
SNCA P37840 2/20 0.37
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
NOTUM Q6P988 1/20 0.37
HTR1A P08908 2/20 0.37
HTR2A P28223 2/20 0.36
CDK4 P11802 2/20 0.36
CCND1 P24385 2/20 0.36
SPR P35270 1/20 0.36
SLC6A4 P31645 1/20 0.36
ITGB2 P05107 1/20 0.36
ICAM1 P05362 1/20 0.36
ITGAL P20701 1/20 0.36
TLR8 Q9NR97 1/20 0.36
TLR7 Q9NYK1 1/20 0.36
MPO P05164 1/20 0.36
HTR2C P28335 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14557960 0.91 PPARG (0.42) CCKBRTRPV1PPARGSNCAMTNR1A
SCHEMBL4602963 0.91 PTPN11 (0.43) CCKBRTRPV1PPARGSNCAHTR1A
SCHEMBL14610514 0.90 CCKBR (0.42) CCKBRCDK4CCND1
SCHEMBL14557929 0.90 CCKBR (0.42) CCKBRCDK4CCND1
SCHEMBL14557964 0.90 HTR2A (0.40) CCKBRTRPV1PPARGNOTUMHTR1A
SCHEMBL14557752 0.90 PPARG (0.41) CCKBRTRPV1PPARGSNCAHTR1A
SCHEMBL14610637 0.89 ICMT (0.41) CCKBRPPARGMTNR1AMTNR1BNOTUM
SCHEMBL14557958 0.89 CCKBR (0.41) CCKBRPPARGMTNR1AMTNR1BNOTUM
SCHEMBL14557751 0.88 PPARG (0.41) CCKBRPPARGSNCAMTNR1AMTNR1B
SCHEMBL14557691 0.88 HTR2A (0.40) CCKBRPPARGMTNR1AMTNR1BNOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R CCKBR 249/4885TRPV1 835/4885PPARG 2181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.